This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
HUMAN HEALTH
We produce bacterial and viral vaccines under a strict innovative policy to achieve the best results
CDMO SERVICES
END-TO-END
CDMO
- Bacterial & viral vaccines up to BSL-2
- Aseptic processing systems
- Process development/optimization
- Scale-up and cGMP manufacturing
- Aseptic filling into vials
- Lyophilization (clinical trial material and large scale)
- Quality control testing: microbiological, sterility and non-sterility, chemical, physical and biological
- Labelling & packaging
- DS & DP release
- Storage: (+2-8°C), (-20°C), (-30°C), (-80°C)
ONE-STOP SHOP ORGANIZATION
Development, clinical phase I-III and commercial manufacturing
COVID-19
CZ Vaccines decided to collaborate actively on the urgent development of solutions against coronavirus disease COVID19 through our research and manufacturing capabilities in several projects.
cGMP
PRODUCTION CAPABILITIES
- cGMP preparation and control of Master and Working Seed Banks of cells, virus and bacteria
- Roller bottles, cell factory & wave bioreactor
- Single use bioreactors: up to 2,000L
- Stainless steel bioreactors: up to 2,000L
- Single use blending mixers: 2 × 3,000L
- Stainless steel vessels: 4 × 6,000L
- State-of the art purification processes: Chromatography (ÄKTA ready), centrifugation, ultrafiltration, diafiltration, tangential flow filtration
CDMO
FILL & FINISH CAPABILITIES
- Liquid and lyophilised products up to BSL-2
- 4 filling machines: 6,000 vials/hour – 2 × 12,000 vials/hour – 24,000 vials/hour
- 2 freeze dryer: up to 24,000 vials per run, and up to 180,000 – 200,000 vials per run
- Component size: 2R-10R-20R
- Manual & automatic visual inspection
- Labelling & packaging
